Guidance for Procurement

Advice to Chief Pharmacists from the NHS Pharmaceutical Quality Assurance Committee


(For assessing the quality of Cannabis-Based Products for Medicinal Use (CBPM) and cannabis-based food supplements).






 The document provides an overview of the quality assurance issues to consider when procuring and supplying cannabis products for medicinal use.


With the exception of Sativex, cannabis-based products available in the UK fall into 3 categories


1. Unlicensed cannabis-based products for medicinal use (CBPM)


2. (Licensed) cannabidiol (CBD)-only medicinal products. Epidyolex is currently the only product in this category


3. Cannabis-based products marketed as food supplements


Specific guidance about the quality of unlicensed cannabis-based products for medicinal use in humans is set out in MHRA Guidance which can be found here.